Diasome

Cleveland, OH · Founded 2004 · Privately Held (backing)

Developer of novel and cell-targeted therapies designed to treat diabetes, obesity, and other metabolic conditions. Diasome is based in Cleveland, OH and was founded in 2004. It has raised $89.7 million.

Last price · $/share
—
Implied valuation
—
Total raised
$89.7M
Last round
—
Valuation — not yet established

No valuation for Diasome is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($89.7M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Diasome with a free account
  • ·Watch Diasome: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Diasome funding history

No rounds on record

No funding rounds for Diasome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Diasome's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Diasome, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Diasome

How much has Diasome raised?
Diasome has raised $89.7M in total funding across its recorded rounds.